Key facts
- This page summarizes Julie Smith's Form 4 filing for EXELIXIS, INC. (EXEL).
- 9 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 19 Feb 2026, 19:18.
Julie Smith - 17 Feb 2026 Form 4 Insider Report for EXELIXIS, INC. (EXEL)
- Reporting relationship
- Director
- Issuer ticker
- EXEL
- Reported as of
- 17 Feb 2026
- Net transaction value
- -$2,626,392
- SEC form
- 4
- Accepted by SEC
- 19 Feb 2026, 19:18:36 UTC
- Prior SEC filing
- 04 Jun 2025
- Next SEC filing
- 29 May 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Nina Ayer, Attorney in Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Julie Smith filed Form 4 for EXELIXIS, INC. (EXEL) on 19 Feb 2026.
Change
- Previous filing in this sequence was filed on 04 Jun 2025.
- Current net transaction value: -$2,626,392.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001557928
Primary reporting owner
Smith Julie
- Relationship
- Director
- Address
- C/O EXELIXIS, INC., 1851 HARBOR BAY PARKWAY, ALAMEDA
- Signature
- /s/ Nina Ayer, Attorney in Fact
- Signature date
- 19 Feb 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
EXEL
transaction
Common Stock
Options Exercise
- Transaction value
- $771,656
- Shares
- +42,422
- Change %
- +206%
- Price
- $18.19
- Shares after
- 63,012
- Date
- 17 Feb 2026
- Ownership
- Direct
- Footnotes
- F1
EXEL
transaction
Common Stock
Sale
- Transaction value
- $1,838,145
- Shares
- -42,422
- Change %
- -67%
- Price
- $43.33
- Shares after
- 20,590
- Date
- 17 Feb 2026
- Ownership
- Direct
- Footnotes
- F1, F2
EXEL
transaction
Common Stock
Options Exercise
- Transaction value
- $854,847
- Shares
- +44,087
- Change %
- +214%
- Price
- $19.39
- Shares after
- 64,677
- Date
- 18 Feb 2026
- Ownership
- Direct
- Footnotes
- F1
EXEL
transaction
Common Stock
Sale
- Transaction value
- $1,961,872
- Shares
- -44,087
- Change %
- -68%
- Price
- $44.50
- Shares after
- 20,590
- Date
- 18 Feb 2026
- Ownership
- Direct
- Footnotes
- F1
EXEL
transaction
Common Stock
Options Exercise
- Transaction value
- $434,451
- Shares
- +20,030
- Change %
- +97%
- Price
- $21.69
- Shares after
- 40,620
- Date
- 18 Feb 2026
- Ownership
- Direct
- Footnotes
- F1
EXEL
transaction
Common Stock
Sale
- Transaction value
- $887,329
- Shares
- -20,030
- Change %
- -49%
- Price
- $44.30
- Shares after
- 20,590
- Date
- 18 Feb 2026
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
EXEL
transaction
Derivative
Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -42,422
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 17 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 42,422
- Exercise price
- $18.19
- Footnotes
- F3
EXEL
transaction
Derivative
Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -44,087
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 18 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 44,087
- Exercise price
- $19.39
- Footnotes
- F4
EXEL
transaction
Derivative
Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -20,030
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 18 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 20,030
- Exercise price
- $21.69
- Footnotes
- F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
Includes 9,812 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.
Footnote F2
Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $44.30 to $44.44. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.
Footnote F3
The option, representing the right to purchase a total of 42,422 shares of Common Stock, became fully exercisable on May 26, 2022.
Footnote F4
The option, representing the right to purchase a total of 44,087 shares of Common Stock, became fully exercisable on June 1, 2023.
Footnote F5
The option, representing the right to purchase a total of 20,030 shares of Common Stock, became fully exercisable on May 31, 2024.